These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23214221)

  • 21. Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis.
    Orloff MJ; Vaida F; Isenberg JI; Wheeler HO; Haynes KS; Jinich-Brook H; Rapier R; Hye RJ; Orloff SL
    J Surg Res; 2012 Nov; 178(1):139-46. PubMed ID: 22480831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.
    Xavier SA; Vilas-Boas R; Boal Carvalho P; Magalhães JT; Marinho CM; Cotter JB
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):652-658. PubMed ID: 29438135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters.
    Sharma SK; Aggarwal R
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1909-15. PubMed ID: 17914969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage.
    Zaman A; Becker T; Lapidus J; Benner K
    Arch Intern Med; 2001 Nov; 161(21):2564-70. PubMed ID: 11718587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Aspartate Aminotransferase to Platelet Ratio Index with Size of Esophageal Varices in Liver Cirrhosis.
    Mandal AK; Subedi P; Paudel MS; Thapa S; Kafle P; Gayam V; Khalid M; Kanth R; Ray NM; Ray S; Gautam S
    J Nepal Health Res Counc; 2019 Apr; 17(1):38-41. PubMed ID: 31110374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can we consider the right hepatic lobe size/albumin ratio a noninvasive predictor of oesophageal varices in hepatitis C virus-related liver cirrhotic Egyptian patients?
    Esmat S; Omarn D; Rashid L
    Eur J Intern Med; 2012 Apr; 23(3):267-72. PubMed ID: 22385886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild hyperbilirubinemia as a marker of oesophageal varices in HCV-related compensated cirrhotic patients.
    Mikuła T; Suchacz MM; Stańczak W; Jabłońska J; Kozłowska J; Cybula A; Cianciara J; Wiercińska-Drapało A
    Pol Merkur Lekarski; 2019 May; 46(275):209-212. PubMed ID: 31152532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding.
    Rudler M; Bureau C; Carbonell N; Mathurin P; Saliba F; Mallat A; Massard J; Golmard JL; Bernard-Chabert B; Dib N; Thabut D;
    Liver Int; 2018 Mar; 38(3):469-476. PubMed ID: 29164762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for esophageal varices in cirrhotic patients - Non-invasive methods.
    Mattos ÂZ; Schacher FC; John Neto G; Mattos AA
    Ann Hepatol; 2019; 18(5):673-678. PubMed ID: 31279653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy.
    Wang J; Wang AJ; Li BM; Liu ZJ; Chen L; Wang H; Shi F; Zhu X
    J Clin Gastroenterol; 2014; 48(10):870-7. PubMed ID: 24296420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.
    Park DK; Um SH; Lee JW; Lee JB; Kim YS; Park CH; Jin YT; Chun HJ; Lee HS; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1042-51. PubMed ID: 15304123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
    Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
    Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NON-INVASIVE PREDICTORS FOR THE PRESENCE, GRADE AND RISK OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH POST-HEPATITIC CIRRHOSIS.
    El Ray A; Azab MM; El-Aziz IM; El-Aleem AA; El-Talkawy MD; El-Badea MA; El Ansary M; Safeem AA; Diab TM
    J Egypt Soc Parasitol; 2015 Aug; 45(2):421-8. PubMed ID: 26485862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices.
    Mattos AZ; Alves de Mattos A; Daros LF; Musskopf MI
    Ann Hepatol; 2013; 12(5):810-4. PubMed ID: 24018500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive laboratory, imaging and elastography markers in predicting varices with high risk of bleeding in cirrhotic patients.
    Petrisor A; Stanescu AMA; Papacocea IR; Panaitescu E; Peagu R; Moldoveanu AC; Fierbinteanu-Braticevici C
    Rom J Intern Med; 2021 Jun; 59(2):194-200. PubMed ID: 33544557
    [No Abstract]   [Full Text] [Related]  

  • 37. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding.
    Reverter E; Tandon P; Augustin S; Turon F; Casu S; Bastiampillai R; Keough A; Llop E; González A; Seijo S; Berzigotti A; Ma M; Genescà J; Bosch J; García-Pagán JC; Abraldes JG
    Gastroenterology; 2014 Feb; 146(2):412-19.e3. PubMed ID: 24148622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet count/splenic size ratio: a parameter to predict the presence of esophageal varices in cirrhotics.
    Sethar GH; Ahmed R; Rathi SK; Shaikh NA
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):183-6. PubMed ID: 16542615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Serum Soluble CD163 in the Diagnosis, Risk of Bleeding, and Prognosis of Gastro-Esophageal Varices in Cirrhotic Patients.
    Fouad R; Hamza I; Khairy M; Elsharkawy M; Helmy AA
    J Interferon Cytokine Res; 2017 Mar; 37(3):112-118. PubMed ID: 28282272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varices.
    Li H; Chen TW; Li ZL; Zhang XM; Li CJ; Chen XL; Chen GW; Hu JN; Ye YQ
    World J Gastroenterol; 2015 Jan; 21(3):988-96. PubMed ID: 25624735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.